Home > Healthcare > Healthcare IT > Artificial Intelligence > AI in Epidemiology Market

AI in Epidemiology Market Size

Report ID: GMI5364
Published Date: Sep 2022
Report Format: PDF

Download Free Sample

AI in Epidemiology Market Size

Artificial Intelligence in Epidemiology Market size was valued at USD 310 million in 2021 and is set to exhibit a CAGR of more than 27% from 2022 to 2030. This growth is a result of the surge in healthcare expenditures fueling the integration of AI and other optimization technologies in epidemiology.

To get key market trends

Download Free Sample

A steady increase in healthcare costs and premiums continues to pose challenges for government organizations worldwide. Many constituents are facing higher out-of-pocket expenses and premiums as a result of this increase. In order to address such issues, artificial intelligence is being deployed to help curb overhead costs through the automation of processes and tasks. The requirement for lowering incremental healthcare costs will thus stimulate the demand for AI in epidemiology, to help reduce supply expenditures.

Artificial Intelligence in Epidemiology Market Report Attributes
Report Attribute	Details
Base Year:	2021
Artificial Intelligence in Epidemiology Market Size in 2021:	313 million (USD)
Forecast Period:	2022 to 2030
Forecast Period 2022 to 2030 CAGR:	27%
2030 Value Projection:	3 billion (USD)
Historical Data for:	2017 to 2021
No. of Pages:	195
Tables, Charts & Figures:	198
Segments covered:	Deployment, Application, End-use, and Region.
Growth Drivers:	Rising adoption of artificial intelligence in epidemiology & disease surveillance Potential to increase the quality of care delivery Need to curb incremental healthcare costs Advancements in Machine Learning, Deep Learning, and Predictive Analytics
Pitfalls & Challenges:	Security concerns regarding patient data Data availability and quality challenges

Learn more about the key segments shaping this market

Download Free Sample

Growing risks of data theft may hamper the industry development

Artificial intelligence technology is deployed to analyze large amounts of patient data. The technology can allow healthcare providers to ensure seamless health service management, disease diagnosis, and care delivery. However, this data contains sensitive personal information, increasing the risks of theft and security breaches. The rising susceptibility to data breaches may pose concerns regarding the use of AI-powered health solutions and in turn, assert a negative influence on the artificial intelligence in epidemiology market dynamics.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global artificial intelligence in epidemiology market was valued at over USD 310 million in 2021 and will exhibit a CAGR of more than 27% between 2022-2030, with increasing healthcare costs and the acceptance of digital platforms.

AI in epidemiology industry share from the research laboratories will be worth over USD 935 million by 2030, given the increasing grants-in-aid from governments to identify the knowledge gap in the healthcare sector.

North America artificial intelligence in epidemiology market is predicted to exhibit a CAGR of more than 26% through 2022-2030, on account of the escalating usage of AI solutions by federal agencies for public health management.

Cognizant Technology Solutions Corporation, Cerner Corporation (Oracle), Microsoft Corporation, Meditech, Siemens Healthineers AG, and SAS Institute, Inc. are some of the key companies holding a considerable portion of the market.